Literature DB >> 11887181

Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency.

David B Corry1, Kirtee Rishi, John Kanellis, Attila Kiss, Li-zhen Song Lz, Jie Xu, Lili Feng, Zena Werb, Farrah Kheradmand.   

Abstract

Clearance of recruited immune cells is necessary to resolve inflammatory reactions. We show here that matrix metalloproteinase 2 (MMP2), as part of an interleukin 13 (IL-13)-dependent regulatory loop, dampens inflammation by promoting the egress of inflammatory cells into the airway lumen. MMP2-/- mice showed a robust asthma phenotype and increased susceptibility to asphyxiation induced by allergens. However, whereas the lack of MMP2 reduced the influx of cells into bronchoalveolar lavage (BAL), numerous inflammatory cells accumulated in the lung parenchyma. BAL of MMP2-/- mice lacked normal chemotactic activity, whereas lung inflammatory cells from the same mice showed appropriate chemotactic responses. Thus, MMP2 establishes the chemotactic gradient required for egression of lung inflammatory cells and prevention of lethal asphyxiation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11887181      PMCID: PMC2814346          DOI: 10.1038/ni773

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  48 in total

Review 1.  Apoptosis in resolution of inflammation.

Authors:  J Savill
Journal:  Kidney Blood Press Res       Date:  2000       Impact factor: 2.687

Review 2.  Corpse clearance defines the meaning of cell death.

Authors:  J Savill; V Fadok
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

Review 3.  Consequences of long-term inflammation. The natural history of asthma.

Authors:  M R Sears
Journal:  Clin Chest Med       Date:  2000-06       Impact factor: 2.878

4.  Functional polymorphism in the gelatinase B gene and asthma.

Authors:  L I Hollá; A Vasků; A Stejskalová; V Znojil
Journal:  Allergy       Date:  2000-09       Impact factor: 13.146

5.  Increased matrix metalloproteinase-9 in the airway after allergen challenge.

Authors:  E A Kelly; W W Busse; N N Jarjour
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

6.  Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B.

Authors:  T Betsuyaku; J M Shipley; Z Liu; R M Senior
Journal:  Am J Respir Cell Mol Biol       Date:  1999-06       Impact factor: 6.914

7.  MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease.

Authors:  D Cataldo; C Munaut; A Noël; F Frankenne; P Bartsch; J M Foidart; R Louis
Journal:  Int Arch Allergy Immunol       Date:  2000-11       Impact factor: 2.749

8.  Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema.

Authors:  T Zheng; Z Zhu; Z Wang; R J Homer; B Ma; R J Riese; H A Chapman; S D Shapiro; J A Elias
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

9.  Gastrointestinal nematode expulsion in IL-4 knockout mice is IL-13 dependent.

Authors:  A J Bancroft; D Artis; D D Donaldson; J P Sypek; R K Grencis
Journal:  Eur J Immunol       Date:  2000-07       Impact factor: 5.532

10.  Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3.

Authors:  G A McQuibban; J H Gong; E M Tam; C A McCulloch; I Clark-Lewis; C M Overall
Journal:  Science       Date:  2000-08-18       Impact factor: 47.728

View more
  96 in total

1.  Rapid and efficient clearance of airway tissue granulocytes through transepithelial migration.

Authors:  J S Erjefält; L Uller; M Malm-Erjefält; C G Persson
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

Review 2.  The future of asthma therapy: integrating clinical and experimental studies.

Authors:  David B Corry; Farrah Kheradmand
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 3.  Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted.

Authors:  Kendra J Greenlee; Zena Werb; Farrah Kheradmand
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

Review 4.  Matrix metalloproteinases and the regulation of tissue remodelling.

Authors:  Andrea Page-McCaw; Andrew J Ewald; Zena Werb
Journal:  Nat Rev Mol Cell Biol       Date:  2007-03       Impact factor: 94.444

5.  Induction of the plasminogen activator system by mechanical stimulation of human bronchial epithelial cells.

Authors:  Eric K Chu; Jason Cheng; John S Foley; Brigham H Mecham; Caroline A Owen; Kathleen J Haley; Thomas J Mariani; Isaac S Kohane; Daniel J Tschumperlin; Jeffrey M Drazen
Journal:  Am J Respir Cell Mol Biol       Date:  2006-06-22       Impact factor: 6.914

6.  Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway.

Authors:  Jennifer Kearley; Karen F Buckland; Sara A Mathie; Clare M Lloyd
Journal:  Am J Respir Crit Care Med       Date:  2009-01-29       Impact factor: 21.405

7.  Systems-level analysis of proteolytic events in increased vascular permeability and complement activation in skin inflammation.

Authors:  Ulrich auf dem Keller; Anna Prudova; Ulrich Eckhard; Barbara Fingleton; Christopher M Overall
Journal:  Sci Signal       Date:  2013-01-15       Impact factor: 8.192

Review 8.  Matrix remodeling in chronic lung diseases.

Authors:  Bon-Hee Gu; Matthew C Madison; David Corry; Farrah Kheradmand
Journal:  Matrix Biol       Date:  2018-03-17       Impact factor: 11.583

9.  Tissue inhibitor of metalloproteinase-1 modulates allergic lung inflammation in murine asthma.

Authors:  Mark F Sands; Patricia J Ohtake; Supriya D Mahajan; Shervin S Takyar; Ravikumar Aalinkeel; Yisheng V Fang; Jessica W Blume; Barbara A Mullan; Don E Sykes; Sandra Lachina; Paul R Knight; Stanley A Schwartz
Journal:  Clin Immunol       Date:  2008-10-26       Impact factor: 3.969

10.  Polarized localization of epithelial CXCL11 in chronic obstructive pulmonary disease and mechanisms of T cell egression.

Authors:  Joanna C Porter; Mary Falzon; Alan Hall
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.